Arcadia Biosciences Income Statement (2014-2025) | RKDA

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter)
0.83M837.00M2.38M4.30M3.22M3.86M1.57M-5.81M1.23M1.30M1.30M0.78M0.99M1.31M1.54M1.22M1.20M1.46M1.30M0.90M
Cost of Revenue (Quarter)
0.86M1.59M2.51M3.75M3.46M3.45M1.13M0.90M0.69M0.65M0.82M0.18M0.47M0.63M1.03M0.83M0.68M0.82M0.88M0.71M
Gross Profit (Quarter)
-0.03M835.41M-0.14M0.55M-0.24M0.41M0.44M-6.71M0.54M0.65M0.48M0.60M0.52M0.67M0.51M0.39M0.52M0.63M0.42M0.19M
Operating items
Research & Development (Quarter)
1.16M1.13M1.04M0.56M0.40M0.36M0.26M0.50M0.36M0.03M0.01M0.01M0.01M0.01M0.02M0.01M0.01M
Selling, General & Administrative (Quarter)
4.07M6.37M6.31M6.21M4.35M4.65M4.18M3.63M4.07M2.07M1.86M1.70M2.06M2.68M2.24M2.65M1.74M2.12M1.57M1.57M
Other Operating Expenses (Quarter)
0.20M-5.41M-0.48M0.33M0.06M-0.07M0.02M4.00M0.75M
Operating Expenses (Quarter)
6.15M9.09M11.09M15.97M7.84M7.64M5.56M5.40M5.10M2.75M2.69M-1.98M2.58M-0.67M3.30M3.50M0.67M1.96M2.45M2.28M
Operating Income (Quarter)
-5.33M-5.42M-2.83M5.59M-4.62M-3.80M-3.99M-4.66M-3.87M-1.45M-1.40M-1.19M-1.59M1.98M-1.76M-0.11M0.53M-0.50M-1.15M0.63M
EBIT (Quarter)
-5.33M-5.42M-2.83M5.59M-4.62M-3.80M-3.99M-4.66M-3.87M-1.45M-1.40M-1.19M-1.59M1.98M-1.76M-0.11M0.53M-0.50M-1.15M0.63M
Non-operating items
Other Non Operating Income (Quarter)
7.46M2.76M-0.01M-0.10M0.01M-0.04M0.04M-0.00M0.03M-0.01M0.02M0.01M0.00M0.15M0.01M-0.14M1.07M1.70M-0.46M
Non Operating Income (Quarter)
7.46M2.76M-0.01M-0.10M0.01M-0.04M0.04M-0.00M0.03M-0.01M0.02M0.01M0.00M0.15M0.01M-0.14M1.07M1.70M-0.46M
Net income details
EBT (Quarter)
-5.33M-5.42M-2.85M5.59M-4.62M-3.80M-2.29M-3.17M-3.87M3.16M-0.64M-0.45M-1.59M1.85M-1.18M-4.03M0.53M-0.50M-1.15M0.63M
Tax Provisions (Quarter)
0.00M0.00M0.00M0.01M0.00M0.01M0.01M
Profit After Tax (Quarter)
1.68M144.00M-2.84M-7.50M-4.61M-3.80M-2.88M-4.47M-9.38M0.82M-0.64M-2.87M-2.42M1.06M-1.18M-4.06M2.60M-4.46M0.86M-1.34M
Equity Income (Quarter)
1.14M
Income from Non-Controlling Interests (Quarter)
-0.38M-0.16M-0.66M-0.28M-0.12M-0.02M-0.01M-0.08M-0.01M
Income from Continuing Operations (Quarter)
-5.33M-5.42M-2.85M5.59M-4.62M-3.80M-2.29M-3.18M-3.87M3.15M-0.64M-0.45M-1.59M1.85M-1.18M-4.04M0.53M-0.50M-1.15M0.63M
Consolidated Net Income (Quarter)
-5.33M-5.42M-2.85M5.59M-4.62M-3.80M-0.59M-1.15M-0.18M-2.01M-0.08M-7.25M-1.48M-0.79M-0.43M-0.03M
Income towards Parent Company (Quarter)
-5.33M-5.42M-2.85M5.59M-4.62M-3.80M-0.59M-1.15M-0.18M-2.01M-0.08M-7.25M-1.48M-0.79M-0.43M-0.03M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
2.06M-5.42M-2.85M5.59M-4.49M-3.80M-0.59M-1.15M-0.18M-2.01M-0.08M-7.25M-1.48M-0.79M-0.43M-0.03M
Additional items
EPS (Basic) (Quarter)
0.11-0.24-0.10-27.30-8.09-6.81-3.71-4.62-10.652.33-1.89-7.21-0.700.78-1.18-4.961.90-3.260.63-0.98
EPS (Weighted Average and Diluted) (Quarter)
0.11-0.24-0.10-27.30-8.09-6.81-4.671.70-10.650.61-1.89-0.22-1.780.78-1.18-2.991.90-3.260.62-0.98
Shares Outstanding (Weighted Average) (Quarter)
19.87M5.86M20.98M0.53M22.19M11.35M13.62M0.60M0.77M0.52M1.20M1.24M1.36M1.36M1.36M1.36M1.37M1.37M1.37M0.19M
Shares Outstanding (Diluted Average) (Quarter)
21.75M20.98M0.53M0.55M0.55M0.61M0.60M0.86M1.36M1.36M1.24M1.36M1.36M1.36M1.36M1.37M1.37M1.37M1.37M
EBITDA (Quarter)
2.06M-5.27M-2.19M-9.26M-4.62M-3.78M-2.87M-4.24M-3.87M0.84M-1.40M-1.19M-1.59M1.98M-1.76M-0.11M0.53M-0.50M-1.15M0.63M
Interest Expenses (Quarter)
0.01M0.00M0.01M-0.00M0.00M
Tax Rate (Quarter)
-0.04%0.02%-0.04%-0.41%0.03%-1.57%-0.20%